La Jolla Pharmaceutical Stock Market Capitalization
| LJPCDelisted Stock | USD 6.22 0.00 0.00% |
La Jolla Pharmaceutical fundamentals help investors to digest information that contributes to La Jolla's financial success or failures. It also enables traders to predict the movement of LJPC Stock. The fundamental analysis module provides a way to measure La Jolla's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to La Jolla stock.
LJPC |
La Jolla Pharmaceutical Company Market Capitalization Analysis
La Jolla's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current La Jolla Market Capitalization | 171.2 M |
Most of La Jolla's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, La Jolla Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of La Jolla Pharmaceutical is about 171.2 M. This is 98.68% lower than that of the Healthcare sector and 96.39% lower than that of the Biotechnology industry. The market capitalization for all United States stocks is 99.1% higher than that of the company.
LJPC Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses La Jolla's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of La Jolla could also be used in its relative valuation, which is a method of valuing La Jolla by comparing valuation metrics of similar companies.La Jolla is currently under evaluation in market capitalization category among related companies.
LJPC Fundamentals
| Return On Equity | 0.0544 | |||
| Return On Asset | 1.64 | |||
| Profit Margin | 10.08 % | |||
| Operating Margin | 4.68 % | |||
| Current Valuation | 242.85 M | |||
| Shares Outstanding | 27.52 M | |||
| Shares Owned By Insiders | 1.91 % | |||
| Shares Owned By Institutions | 71.79 % | |||
| Number Of Shares Shorted | 202.51 K | |||
| Price To Earning | 38.88 X | |||
| Price To Book | 30.11 X | |||
| Price To Sales | 3.29 X | |||
| Revenue | 52.01 M | |||
| Gross Profit | 63.08 M | |||
| EBITDA | 4.09 M | |||
| Net Income | 5.24 M | |||
| Cash And Equivalents | 44.56 M | |||
| Cash Per Share | 1.74 X | |||
| Total Debt | 124.8 M | |||
| Debt To Equity | 7.16 % | |||
| Current Ratio | 3.92 X | |||
| Book Value Per Share | (3.36) X | |||
| Cash Flow From Operations | 13.59 M | |||
| Short Ratio | 0.46 X | |||
| Earnings Per Share | (1.44) X | |||
| Price To Earnings To Growth | 11.72 X | |||
| Number Of Employees | 61 | |||
| Beta | 1.97 | |||
| Market Capitalization | 171.2 M | |||
| Total Asset | 89.52 M | |||
| Retained Earnings | (1.06 B) | |||
| Working Capital | 79.5 M | |||
| Current Asset | 86.74 M | |||
| Current Liabilities | 7.24 M | |||
| Z Score | -14.8 |
About La Jolla Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze La Jolla Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of La Jolla using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of La Jolla Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in LJPC Stock
If you are still planning to invest in La Jolla Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the La Jolla's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |